A

Achilles Therapeutics (ACHL)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Achilles Therapeutics (ACHL)

Achilles Therapeutics PLC provides pharmaceuticals products. The Company offers therapies that target truncal tumour neo-antigens. Achilles Therapeutics serves customers in the United Kingdom.

  • 1.28
  • 1.42
  • 1.20
  • 5.65
  • -29.6%
  • --
  • 118.47k
  • 36.34k
  • 72M
  • 1.31
  • -72.2%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.